Latest News
Conference Coverage
Biologics gaining traction in children with moderate to severe psoriasis
Latest News
Here comes bimekizumab, the newest IL-17 inhibitor
KAUAI, HAWAII – “If this holds up in phase 3, it’s going to be a new world for our patients and for us, ” said Craig L. Leonardi, MD.
Conference Coverage
Get ready for certolizumab for psoriasis
KAUAI, HAWAII – Women of childbearing potential may prefer it.
News
CV risk factors go undiagnosed, untreated in many psoriatic patients
Study of more than 2,000 patients at eight centers in Canada, the United States, and Israel.
Latest News
Make a PEST of your psoriasis patients
KAUAI, HAWAII – Every psoriasis patient should complete the Psoriasis Epidemiology Screening Tool (PEST) for psoriatic arthritis annually.
Conference Coverage
Meta-analysis: Lifestyle changes improve psoriasis
GENEVA – Obese patients can reduce psoriasis severity and boost quality of life with diet or exercise.
Conference Coverage
Ixekizumab beats ustekinumab for fingernail psoriasis, hands down
GENEVA – Clear nails in half of ixekizumab users by week 24.
News
Mood changes reported in cases of methotrexate use for dermatologic disease
Neurotoxicity is a rare side effect of methotrexate use, as seen in two children treated for dermatologic disease.
Conference Coverage
Prior biologic exposure doesn’t diminish ixekizumab’s efficacy
GENEVA – Ixekizumab works “extraordinarily well” for psoriasis – even with prior exposure to other IL-17 inhibitors.
Latest News
Minorities less likely to seek treatment for psoriasis
“While psoriasis is less common among minorities than whites, minorities may suffer from a larger burden of disease yet have fewer visits.”